GILEAD SCIENCES, INC.

(GILD)
  Report
Real-time Estimate Cboe BZX  -  05/24 11:58:26 am EDT
63.90 USD   +0.37%
05/23WALL STREET STOCK EXCHANGE : Biden comments reassure investors
05/23SVB Securities Initiates Gilead Sciences at Market Perform With $68 Price Target
MT
05/23ANALYST RECOMMANDATIONS : AbbVie, Amgen, Caterpillar, HP, Nike...
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Sector news Bio Therapeutic Drugs
11:13aGoldman Sachs Adjusts BioNTech's Price Target to $206 from $255, Keeps Neutral Rating
MT
05/23Top Midday Gainers
MT
05/23Catalyst Biosciences Stock Surges After Vertex Pharmaceuticals Buys Catalyst's Compleme..
MT
05/23SVB Securities Initiates Regeneron Pharmaceuticals at Outperform with $738 Price Target
MT
05/23Catalyst Biosciences Shares Soar After Complement Portfolio Sale
DJ
05/23What you need to know about the coronavirus right now
RE
05/23Pfizer, BioNTech Say Third Dose of COVID-19 Vaccine About 80% Effective in Children Age..
MT
05/23Pfizer, BioNTech Publish Data Supporting COVID-19 Vaccine Efficacy In Children Aged Six..
MT
05/23SVB Securities Initiates Regeneron Pharmaceuticals at Outperform With $738 Price Target
MT
05/23SVB Securities Initiates Vertex Pharmaceuticals at Market Perform With $265 Price Targe..
MT
05/23Regeneron's Phase 3 Trial Data Shows Positive Results for Potential Treatment of Rare H..
MT
05/23VERTEX PHARMACEUTICALS INCORPORATED : VRTX) acquired Complement Portfolio of Catalyst Bio..
CI
05/20Regeneron, Sanofi Receive US FDA Approval of Dupixent for Eosinophilic Esophagitis
MT
05/20Sanofi's Dupixent wins U.S. approval for bigger use
RE
05/20FDA Grants Regeneron Approval for Dupixent in Inflammatory Disorder Treatment
DJ
05/20EU Member States Seek Changes To Supply Contracts For COVID-19 Jabs Amid Declining Dema..
MT
05/19US Health Agency Approves Pfizer-BioNTech's COVID-19 Booster Jab For Children
MT
05/19EU health regulator backs using AstraZeneca COVID shot as booster
RE
05/19European ADRs Move Higher in Thursday Trading
MT
05/18Vertex Pharmaceuticals Incorporated Elects Suketu Upadhyay as Independent Director
CI
05/17Pfizer-BioNTech COVID-19 Vaccine Booster Approved for Children 5 to 11 Years Old in US
MT
05/17UBS Adjusts BioNTech Price Target to $168 From $170, Maintains Neutral Rating
MT
05/17Pfizer, BioNTech Receive US Approval for COVID-19 Jab Booster Dose for Children
MT
05/17Pfizer Gets FDA Emergency Use Authorization for COVID-19 Vaccine as Booster Dose in Chi..
MT
05/17FDA Expands Authorization of Pfizer Covid Booster to Kids 5 to 11
DJ
05/17PRESS RELEASE : Coronavirus (COVID-19) Update: FDA Expands Eligibility for Pfizer-BioNTech..
DJ
05/17Vertex Pharmaceuticals Pledges $50 Million to Health Equity
MT
05/17Vertex Pharmaceuticals Incorporated Announces Further Expansion in the Boston Seaport A..
CI
05/17WuXi Apptec Eyes Issue of Over 78 Million Shares in Hong Kong Under Mandate
MT
05/16European ADRs Move Higher in Monday Trading
MT
05/15Pfizer, BioNTech Agree To Move Delivery Schedules For COVID-19 Vaccines In EU
MT
05/11Pfizer's $11.6 billion Biohaven buy could spark more biotech deals
RE
05/11European ADRs Move Sharply Higher in Wednesday Trading
MT
05/11BIONTECH : Goldman Sachs sticks Neutral
MD
05/10TRANSCRIPT : Regeneron Pharmaceuticals, Inc. Presents at Bank of America 2022 Healthcare C..
CI
05/10Morgan Stanley Lowers BioNTech SE's Price Target to $195 From $197, Equalweight Rating ..
MT
05/10What you need to know about the coronavirus right now
RE
05/09BIONTECH : JP Morgan reiterates its Neutral rating
MD
05/09SECTOR UPDATE : Health Care Stocks Declining Ahead of Monday Close
MT
05/09SECTOR UPDATE : Health Care Stocks Slide with Broader Monday Markets
MT
05/09BioNTech Q1 Results Top Street Estimates; Shares Gain
MT
05/09UBS Adjusts Vertex Pharmaceuticals Price Target to $321 From $322, Maintains Buy Rating
MT
05/09BIONTECH : Jefferies reiterates its Neutral rating
MD
05/09BioNTech Q1 Earnings, Revenue Surge; Shares Rise Pre-Bell
MT
05/09TRANSCRIPT : BioNTech SE, Q1 2022 Earnings Call, May 09, 2022
CI
05/09Equities Slide Pre-Bell as US Signals More Losses; Europe, Asia Retreat
MT
05/09Wall Street Leans Back Pre-Bell; Europe Off, Asia Down
MT
05/09BioNTech Reiterates 2022 Vaccine Revenue Guidance After Boost In Q1 Earnings
MT
05/09COVID vaccine makers shift focus to boosters
RE
05/09Earnings Flash (BNTX) BIONTECH SE Posts Q1 EPS EUR14.24
MT
1  2  3  4  5  6  7  8  9  10Next
Official Publications
Upcoming event on GILEAD SCIENCES, INC.